Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
5(50.0%)
N/A
2(20.0%)
Phase 3
1(10.0%)
Phase 4
1(10.0%)
Early Phase 1
1(10.0%)
10Total
Phase 2(5)
N/A(2)
Phase 3(1)
Phase 4(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)